大灣區港股企業可有序回深上市，哪些公司能趕上風口？（附名單）
日前發佈的《關於深入推進深圳綜合改革試點深化改革創新擴大開放的意見》（簡稱《意見》）政策文件中，首次明確表示，允許香港上市的粵港澳大灣區企業迴歸深圳交易所上市。
《意見》表示，健全金融服務實體經濟的激勵約束機制。支持深圳開展科技產業金融一體化專項試點。健全科技型企業信貸、知識產權證券化、科技成果和知識產權交易等實踐場景和規則體系。優化科技型企業債權和股權融資協同銜接機制。深化綠色金融改革。支持保險資金依法合規投資在深圳發起設立的主要投向特定領域的私募股權投資基金和創業投資基金。允許在香港聯合交易所上市的粵港澳大灣區企業，按照政策規定在深圳證券交易所上市。
簡單來看，在港上市的企業常見的架構分為兩類，即紅籌架構和H股架構。其中此次《意見》出台後，紅籌架構企業回A上市備受關注。
從深交所的上市條件來看，深交所主板針對已在境外上市的紅籌企業二次上市給出了2套標準，滿足其一即可：
1、市值不低於2000億元；
2、市值200億元以上，擁有自主研發、國際領先技術，科技創新能力較強，在同行業競爭中處於相對優勢地位。
而創業板目前只針對“未在境外上市的紅籌企業”。
因此，我們僅簡單以市值200億元以上未在A股上市的粵港澳企業作為篩選條件，大致瞭解一下可能符合條件的企業有哪些，當然準確的名單需要後續詳細的政策跟蹤和進一步探討。
根據Wind數據統計，截至2025年6月12日，H股共有上市公司2629家；其中，註冊地在粵港澳但未在內地上市的港股公司一共有1583家，總市值在200億元以上的公司有101家。
這些公司主要集中在醫療保健、信息技術、通訊服務、消費、金融、公用事業等行業，其中不僅包括騰訊控股、小鵬汽車-W這樣的大型企業，也包括近期大熱的醫藥公司，如石藥集團、中國生物製藥、康方生物、和黃醫藥等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
